ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 168.46 USD -0.23% Market Closed
Market Cap: 4.1B USD
Have any thoughts about
ICU Medical Inc?
Write Note

ICU Medical Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ICU Medical Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Revenue
$2.3B
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
23%
Haemonetics Corp
NYSE:HAE
Revenue
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
4%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Revenue
$3.9B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Revenue
$4B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.5B
CAGR 3-Years
57%
CAGR 5-Years
34%
CAGR 10-Years
18%
Merit Medical Systems Inc
NASDAQ:MMSI
Revenue
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

ICU Medical Inc
Revenue Breakdown

Breakdown by Geography
ICU Medical Inc

Total Revenue: 2.3B USD
100%
United States: 1.4B USD
63.7%
EMEA: 373.6m USD
16.5%
Apac [Domain]: 241.7m USD
10.7%
Other Foreign Countries: 203.8m USD
9%
Show More
Show Less

Breakdown by Segments
ICU Medical Inc

Total Revenue: 2.3B USD
100%
Infusion Consumables: 969.1m USD
42.9%
Vital Care: 661m USD
29.3%
Infusion Systems: 629m USD
27.8%

ICU Medical Inc
Glance View

Market Cap
4.1B USD
Industry
Health Care

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.

ICUI Intrinsic Value
190.76 USD
Undervaluation 12%
Intrinsic Value
Price

See Also

What is ICU Medical Inc's Revenue?
Revenue
2.3B USD

Based on the financial report for Sep 30, 2024, ICU Medical Inc's Revenue amounts to 2.3B USD.

What is ICU Medical Inc's Revenue growth rate?
Revenue CAGR 10Y
23%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for ICU Medical Inc have been 22% over the past three years , 13% over the past five years , and 23% over the past ten years .

Back to Top